Typhoid Fever
What's New
Last Posted: Mar 15, 2023
- Whole Exome Sequence Analysis for Inborn Errors of IL-12/IFN-? Axis in Patient with Recurrent Typhoid Fever.
Hassan Faaiz Ul, et al. BioMed research international 2023 0 1761283 - Use of whole genome sequencing to complement characterisation of a typhoid fever outbreak among a Marshallese community: Oklahoma, 2015.
Burnsed L J, et al. Epidemiology and infection 2018 0 e11 - Gallbladder carriage generates genetic variation and genome degradation in Salmonella Typhi.
Thanh Duy Pham, et al. PLoS pathogens 2020 0 (10) e1008998 - Temporal fluctuation of multidrug resistant salmonella typhi haplotypes in the mekong river delta region of Vietnam.
Holt Kathryn E, et al. PLoS neglected tropical diseases 2011 0 (1) e929 - Systematic review of the clinical manifestations of glucose-6-phosphate dehydrogenase deficiency in the Greater Mekong Subregion: implications for malaria elimination and beyond.
Ong Ken Ing Cherng et al. BMJ global health 2017 2(3) e000415 - The role of TLR4 896 A>G and 1196 C>T in susceptibility to infections: a review and meta-analysis of genetic association studies.
Ziakas Panayiotis D, et al. PloS one 2013 0 (11) e81047 - Toll-like receptor 4 Asp299Gly and Thr399Ile polymorphisms and typhoid susceptibility in Asian Malay population in Malaysia.
Bhuvanendran Saatheeyavaane, et al. Microbes and infection / Institut Pasteur 2011 9 (10) 844-51 - Typhoid fever
From NCATS Genetic and Rare Diseases Information Center - Toll-like receptor 4 (TLR4) and typhoid fever in Vietnam.
Nguyen Thi Hue, et al. PloS one 2009 0 (3) e4800 - A TNF region haplotype offers protection from typhoid fever in Vietnamese patients.
Dunstan Sarah J, et al. Human genetics 2007 8 (1) 51-61 - Polymorphisms in proinflammatory genes and susceptibility to typhoid fever and paratyphoid fever.
Ali Soegianto, et al. Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research 2007 4 (4) 271-9 - PARK2/PACRG polymorphisms and susceptibility to typhoid and paratyphoid fever.
Ali S, et al. Clinical and experimental immunology 2006 6 (3) 425-31 - Host susceptibility and clinical outcomes in toll-like receptor 5-deficient patients with typhoid fever in Vietnam.
Dunstan Sarah J, et al. The Journal of infectious diseases 2005 4 (7) 1068-71 - Susceptibility to typhoid fever is associated with a polymorphism in the cystic fibrosis transmembrane conductance regulator (CFTR).
van de Vosse Esther, et al. Human genetics 2005 10 (1) 138-40 - Genes of the class II and class III major histocompatibility complex are associated with typhoid fever in Vietnam.
Dunstan S J, et al. The Journal of infectious diseases 2001 1 (2) 261-268 - HLA-DRB1*12 is associated with protection against complicated typhoid fever, independent of tumour necrosis factor alpha.
Dharmana E, et al. European journal of immunogenetics : official journal of the British Society for Histocompatibility and Immunogenetics 2002 8 (4) 297-300
About Rare Diseases PHGKB
Rare Disease PHGKB is an online, continuously updated, searchable database of published scientific literature, CDC and NIH resources, and other information that address the public health impact and translation of genomic and other precision health discoveries into improved health outcomes related to rare diseases...more
Content Summary
Selected Rare Diseases
- Alpha-1 Antitrypsin Deficiency
- Amyotrophic Lateral Sclerosis
- Brugada Syndrome
- Cerebral Palsy
- Cystic Fibrosis
- Duchenne Muscular Dystrophy
- Eclampsia
- Erythema Multiforme
- Familial Mediterranean Fever
- Fragile X Syndrome
- Gaucher Disease
- Glomerulonephritis
- Graves Disease
- Hemophilia
- Huntington Disease
- Microcephaly
- Myasthenia Gravis
- Phenylketonuria
- Retinitis Pigmentosa
- Severe Combined Immunodeficiency
Disclaimer: Articles listed in the Public Health Knowledge Base are selected by Public Health Genomics Branch to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.
- Page last reviewed:Feb 1, 2024
- Page last updated:May 03, 2024
- Content source: